|
- ASN 2025: Previewing Advances in Glomerular Disease - Medscape
Dr Pietro A Canetta anticipates discussions at ASN on advances in glomerular disease, including new KDIGO guidelines and therapies
- Experts Elevate New Drugs for Diabetic Kidney Disease - Medscape
A consensus statement from the ADA and KDIGO recommends more aggressive combined use of several newer, and costly, drug classes to slow progression of diabetic kidney disease
- Taper, Dose Down, Discontinue: Striving for Less Steroid Use
Now in the 75th year since the first presentation on the clinical use of glucocorticoids, what consensus has been reached in sparing their use to avoid their many potential adverse effects?
- Diabetes in chronic kidney disease: guidelines recommend . . . - Medscape
An update from KDIGO, an independent organization that aims to improve the care of patients with kidney disease worldwide A layered approach is recommended while caring for patients with diabetes
- A PCP Guide to Emerging Therapies for Resistant Hypertension
The Kidney Disease: Improving Global Outcomes (KDIGO) guidelines for patients with chronic kidney disease state that normal blood pressure should be below 120 80, which is very hard to do
- Major Changes Highlighted in New CKD Management Guidelines
Use of cystatin C for chronic kidney disease evaluation and sodium–glucose cotransporter-2 inhibitors as first-line therapy are among the changes put forth by KDIGO
- Semaglutide Significantly Improves Chronic Kidney Disease
The landmark FLOW study shows the benefits extend to kidney, cardiovascular, and mortality outcomes in high-risk patients with type 2 diabetes and CKD
- Managing CKD-Associated Pruritus - Medscape
Itching is often the most debilitating cutaneous symptom of CKD and ESRD Experts recommend a stepwise treatment approach that may include a new biologic agent for recalcitrant cases
|
|
|